-
Alemtuzumab, sold
under the
brand names Campath and
Lemtrada among others, is a
medication used to
treat chronic lymphocytic leukemia and
multiple sclerosis...
- ****ociated with
certain types of lymphoma. It is the
protein targeted by
alemtuzumab, a
monoclonal antibody used for the
treatment of
chronic lymphocytic...
-
Design Labs, Inc. in
Mountain View, California, in the 1980s and 1990s.
Alemtuzumab is an
early example of an
antibody whose humanization did not include...
-
tumor cell.
Examples include rituximab, ofatumumab, elotuzumab, and
alemtuzumab.
Antibodies under development have
altered Fc
regions that have higher...
- measures.
There is high
confidence that natalizumab, cladribine, or
alemtuzumab are
decreasing relapses over two
years for
people with RRMS. Natalizumab...
-
proteins with its Fc region. MAbs
approved by the FDA for
cancer include:
Alemtuzumab Bevacizumab Cetuximab Dostarlimab Gemtuzumab ozogamicin Ipilimumab Nivolumab...
- doxorubicin, prednisone, etoposide, cyclophosphamide,
bleomycin VAPEC-B).
Alemtuzumab (Campath), a
monoclonal antibody that
attacks white blood cells, has...
- malaria)
Medications –
chemotherapy (antilymphocyte
globulin therapy,
alemtuzumab, glucocorticoids)
Radiation Major surgery Miscellaneous – ECMO, kidney...
-
kinase inhibitors, beta-glycan peptides, halofuginone, basiliximab,
alemtuzumab, abatacept, and
haematopoietic stem cell transplantation. As of 2012[update]...
-
Electron therapy Conventional radiation therapy Photopheresis Interferons Alemtuzumab (Campath-1H)
Methotrexate Pentostatin and
other purine analogues (Fludarabine...
